about
Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infectionExtraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosisDipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity3-dimensional imaging of collagen using second harmonic generation.Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance.CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liver.Gene array analysis and the liver.Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality.Pathogenesis and management of alcoholic hepatitis.Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis.Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liverThe hepatic transcriptome in human liver diseaseRegulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.The in vivo expression of dipeptidyl peptidases 8 and 9.Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.The dipeptidyl peptidase IV family in cancer and cell biology.The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis.Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience.Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy.Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth.Kynurenine Aminotransferases and the Prospects of Inhibitors for the Treatment of Schizophrenia.Dipeptidyl peptidase 9 enzymatic activity influences the expression of neonatal metabolic genes.Hepatocellular carcinoma: Mouse models and the potential roles of proteases.Dipeptidyl peptidase 9 substrates and their discovery: current progress and the application of mass spectrometry-based approaches.Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin.The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury.T and B lymphocyte subsets in spermatic granulomas in five rams.Langerhans cells in the development of skin cancer: a qualitative and quantitative comparison of cell markers in normal, acanthotic and neoplastic ovine skin.Major histocompatibility complex antigens in normal, acanthotic and neoplastic ovine skin: an association been tumor invasiveness and low level MHC class I expression.A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling.Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease.Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line.Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity.Tumour necrosis factor and interleukin 6 production during interaction between activated CD4+ lymphocytes and simian immunodeficiency virus-infected macrophages.Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study.Hepatic covalent adduct formation with zomepirac in the CD26-deficient mouse.Lentivirus induced arthritis in animals.First bite.
P50
Q26995871-5B094422-9675-4FEE-B2B3-AC6F930D9EE8Q28218916-00918238-6309-42E8-B27A-CB04D0620AF5Q28240532-FED53CFE-EC6D-4FEF-B751-D127254C261BQ28271177-5EADC0BC-84F8-4199-BF6B-AD94D1B6353DQ31130928-B242F766-254C-42B4-A16D-5297E793D1ADQ33916624-CA0E27F8-2092-4B10-A30F-C0368AE7B86DQ34368489-1564E7DB-6D44-4FD8-AC2F-050477A5DD1FQ34760613-49630729-92EA-47BA-AE0C-3F671F11E8BCQ35007261-B661DA6A-38D5-4352-BB89-D436A2E74295Q35040181-C5FE46B3-CEC5-4D1C-94E4-EE267D792AF9Q35607638-91E891A0-06B1-46AB-8B2D-FED8BD9BCD44Q35691528-B71B0F02-5D55-4775-B749-1924134718CFQ35843317-4F1E2AB0-3246-43C0-8D7F-EA01E876E435Q36647336-2E918933-3F32-4BE0-B1B7-7D68BA1B5A43Q36865097-29D43170-FF7D-44B3-A185-8AA1A99EA07BQ37389403-CA3C7E3B-F580-4AA5-A37D-D416427D1A17Q37410661-A715510D-875D-4AF9-B921-70A2D1983953Q37674999-39A1B541-2799-4568-A191-B88793E6760AQ37771966-C9ED9C7A-ECAA-4D97-A032-0A51D496256BQ37837059-3B6F8E8A-E401-46E4-84AF-BC04DDC5FE48Q38182507-E32CDC8D-7FE1-4514-B413-FF7D18354E1FQ38356556-C3808E2B-A745-4E5D-BF47-C4FD73919FCEQ38519440-EAF3A24F-AB76-445A-B6E0-67B2DDCA3F87Q38789910-F171A00F-F31D-4A7C-9423-39D5B10311F2Q38798378-72B06911-6478-4BA3-89BD-36A02A463EF5Q38842469-460F638E-06D0-4A2D-8BBF-879449D34470Q38930954-C16325D5-0FF0-4F73-891C-037C249DE887Q39144304-A43FCD66-29DE-4746-A765-5534D4FAE6F3Q39431077-1CC701D9-A70D-4B1F-AC21-F9ED78AB11E4Q39531552-343CBC32-FD76-4054-8CF4-4C64DE3E407FQ39531558-3DAD26EF-5FF8-426B-B488-49106698C518Q39534167-651B9834-9217-4872-9BAE-7E64AD1A4049Q40010594-74656A1D-2140-44ED-A987-64132CA45842Q40370679-C1553FF2-7471-4CB4-B66C-3F4928778142Q41359934-0F5BA34F-6489-4AA8-B1C2-32DCE4A01E1AQ41627176-DD9A69D7-B028-4F0B-899A-63B1F029AE3CQ41686499-4564010B-1491-41B7-A0B7-EA258C4ABB5CQ43918476-121CB290-A00F-494E-9BAA-49B22BE2EB57Q44091077-79D6AA99-8BB6-4E82-92A4-731B3D80522DQ44255199-3C695EBB-635E-444F-8BAA-A28C00171003
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mark D. Gorrell
@ast
Mark D. Gorrell
@en
Mark D. Gorrell
@es
Mark D. Gorrell
@sl
type
label
Mark D. Gorrell
@ast
Mark D. Gorrell
@en
Mark D. Gorrell
@es
Mark D. Gorrell
@sl
prefLabel
Mark D. Gorrell
@ast
Mark D. Gorrell
@en
Mark D. Gorrell
@es
Mark D. Gorrell
@sl
P106
P1153
7003898943
P21
P31
P496
0000-0002-0528-2604